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Separation of cancer cells from white blood cells
by pinched flow fractionation†
Marie Pødenphant,a Neil Ashley,b Kamila Koprowska,b Kalim U. Mir,c
Maksim Zalkovskij,d Brian Bilenberg,d Walter Bodmer,b Anders Kristensena
and Rodolphe Marie*a
In this paper, the microfluidic size-separation technique pinched flow fractionation (PFF) is used to separate
cancer cells from white blood cells (WBCs). The cells are separated at efficiencies above 90% for both cell
types. Circulating tumor cells (CTCs) are found in the blood of cancer patients and can form new tumors.
CTCs are rare cells in blood, but they are important for the understanding of metastasis. There is therefore
a high interest in developing a method for the enrichment of CTCs from blood samples, which also
enables further analysis of the separated cells. The separation is challenged by the size overlap between
cancer cells and the 106 times more abundant WBCs. The size overlap prevents high efficiency separation,
however we demonstrate that cell deformability can be exploited in PFF devices to gain higher efficiencies
than expected from the size distribution of the cells.
1. Introduction
Circulating tumor cells (CTCs) are cells that have been shed
from a tumor and entered the blood circulation. When shed
from the primary tumor following adaptation to and coloni-
zation of the microenvironment of a secondary site, they
form metastases which are responsible for over 90% of solid
tumor-related deaths.1 CTCs, obtained through a simple
venipuncture, can serve as a “liquid biopsy” to monitor
tumor characteristics in real-time, including inter- and intra-
tumoral heterogeneity. However, CTC isolation and subse-
quent characterization are technically challenging due to the
low numbers among an abundance of white blood cells. A
wide range of analytical methods for CTC detection, enrich-
ment and isolation has been developed. They exploit CTC-
specific properties, either biological such as surface marker
expression or physical e.g. size, density or stiffness. Most of
the available platforms utilize immunomagnetic capture
using antibodies targeting the epithelial cell adhesion
molecule-1 (EpCAM). Subsequent CTC detection is based on
either direct antibody-based methods such as immunocyto-
chemistry (ICC), immunofluorescence (IF) and fluorescence-
activated cell sorting (FACS), or indirect nucleic acid-based
methods which measure mRNA transcripts by reverse
transcriptase-polymerase chain reaction (RT-PCR), or direct
DNA isolation and sequencing.2 So far the only Food and
Drug Administration (FDA) approved technology for the clini-
cal monitoring of CTC counts in cancer patients is the
CellSearch® system (Veridex). This system is based on an ini-
tial step of immunomagnetic enrichment of EpCAM-positive
cells. Subsequent enumeration of CTCs is done using fluores-
cent microscopy to identify DAPI-positive, cytokeratin-positive
and CD45-negative cells.3 AdnaTest® (AdnaGen AG) is an
example of a system combining immunomagnetic enrichment
of epithelial (EpCAM-positive) cells with multiplex RT-PCR to
identify putative gene transcripts.4 Another strategy for the
identification of CTCs is to enumerate and analyze proteins
specifically secreted by viable tumor cells by use of EPISPOT
(EPIthelial ImmunoSPOT). First CTCs are enriched by nega-
tive depletion using CD45 and subsequently cultured on a
membrane coated with antibodies that capture secreted pro-
teins such as cytokeratin 19, mucin 1, prostate-specific anti-
gen or fibroblast growth factor 2.5 All antibody-based capture
technologies have limitations as they likely capture only a
subpopulation of the CTCs. Furthermore, most of them have
high initial and running costs and require user specialization
which limits wide spread use of these systems. In contrast
passive size-separation in microfluidic devices is an alterna-
tive approach that is label-free and can potentially be
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performed on cost-effective single use devices, if they can be
mass-produced. Microfluidic separation devices are also easy
to operate and have low running costs especially if a simple
pressure-driven flow is used to operate the device.6–9
Rare cells have been separated from red blood cells (RBCs)
and WBCs using different continuous label-free size-separa-
tion techniques. A successful separation is usually character-
ized by high recovery of the cancer cells, high removal of
WBCs and RBCs,‡ and high sample throughput.
Geislinger et al. used non-inertial lift forces to sort MV3
skin cancer cells and RBCs with recoveries up to 100% for
the cancer cells and a removal of 98% to 99% of the red
blood cells.10 This was done at a throughput in the order of
106 cells per min. The MV3-cell line has an average size of 14
μm ± 2 μm, which is within the size range of WBCs, however
in this study the removal of WBCs was not investigated.
Loutherback et al.11 used deterministic lateral displacement
arrays to separate MDA-MB-231 breast cancer cells from
diluted whole blood. They measured a recovery of 86% at 10
mL min−1, but with a blood cell removal of only 75%. Bhagat
et al.12 used inertial microfluidics to separate MCF-7 and
MDA-MB-231 breast cancer cells spiked in whole blood with
a recovery over 80% at a throughput of 108 cells per min.
They measured a removal of both WBCs and RBCs of over
99%. The MCF-7 and MDA-MB-231 cell lines are relatively
large with an average diameter of approx. 18 μm,12 conse-
quently there is no size-overlap between these cancer cells
and WBCs and it is not surprising that Loutherback et al.
and Bhagat et al. measured such high recoveries and blood
cell removals. The average diameter of CTCs is approx. 15
μm, but can be smaller, depending on their origin, which
increases the size-overlap between WBCs and CTCs and is
thus a challenge for any size-separation technique.
We use pinched flow fractionation (PFF) to separate WBCs
from LS174T colon cancer cells. We chose LS174T cell as a
convenient well characterised colorectal cancer derived cell
line to model CTCs as their characteristics and size closely
match those of CTCs. PFF is a continuous size-separation
technique first presented by Yamada et al.13 The principle of
our PFF devices is shown in Fig. 1. Briefly, a sample
containing particles of different sizes is placed in one inlet
and a carrier solution is placed in the other inlet. The solu-
tions from both inlets are then pushed into the device, where
they meet at a narrow channel called the pinched segment.
The particles then get aligned against the channel side-wall
under the high flow from the carrier solution, and they follow
streamlines according to the position of their center of mass.
Downstream, the pinched segment is split into three outlet
channels: a small and large particle outlet channel, and a
drain channel. Particles with a diameter below and above the
critical diameter, dc, will flow towards the small and large
particle outlet respectively, while the drain collects most of
the buffer fluid to prevent dilution. The critical diameter dc
can be adjusted by applying a pressure to the drain outlet
and thus the devices can be adapted to any sample. We refer
to this operation of the device as adjustable-PFF in the follow-
ing. The PFF technique was first used to separate microbeads
of different sizes using increasingly refined designs.14,15 PFF
has also been applied to biological samples and used for sep-
aration of RBCs and WBCs,16 and detection of single nucleo-
tide polymorphisms.17 Recently we used PFF to remove fat
particles from cow milk samples for improved cell analysis.18
In this paper, we perform the separation of LS174T cancer
cells from WBCs using PFF in order to mimic the isolation of
CTCs from WBCs. Whole blood samples can rapidly be
centrifuged to separate WBCs and CTCs from the remaining
blood cells, and separating CTCs from WBCs is thus critical
in isolating CTCs. We use LS174T colorectal adenocarcinoma
cells as models for CTCs. They have a measured average size
of 13.6 ± 2.1 μm, which is closer in size to CTCs than the
often used breast cancer cell-lines. The LS174T cells have a
large size overlap with WBCs, which vary in size from 5 μm
up to 15 μm, see Fig. S1 in the ESI.† In our sample the WBCs
have an average size of 7.1 ± 1.0 μm. We could thus expect a
good removal of WBCs using an ideal separation with a criti-
cal diameter dc of 10 μm i.e. where all particles smaller than
the critical diameter end up in the outlet for small particles.
However, since the separation is not ideal for particles with a
diameter close to dc, we expect the size overlap of the two cell
‡ Recovery is calculated as the percentage of cancer cells in the targeted outlet
compared to the total number of cancer cells in all outlets. Removal is the per-
centage of blood cells removed from the targeted outlet compared to the total
number of blood cells in all outlets.
Fig. 1 Sketch of the PFF device fabricated by injection molding with
five Luer fittings used as inlets and outlets. The principle of PFF, where
particles are aligned and then sorted by size into different outlets.
Particles with a diameter smaller than the critical diameter, dc, flow
towards the small particle outlet, and particles larger than dc flow
towards the large particle outlet. The drain collects most of the carrier
solution. Channel dimensions that affect the critical diameter are
shown. The four widths denote width of: the pinched segment (Wp),
the small particle outlet channel (Ws), the large particle outlet channel
(Wl), and the drain channel (Wd).
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types to decrease the removal of the WBCs. We demonstrate
that a difference in cell deformability is the most likely rea-
son for the unexpected separation efficiency, and show that
we can exploit the apparent relatively large deformability of
the WBCs to achieve both a cancer cell recovery and a WBC
removal over 90%, which is better than expected from the
size distribution of each cell type.
2. Materials and methods
2.1. Design
The PFF devices have two inlets and three outlets. The first
outlet is for particles with a diameter below dc, the second
for particles with a diameter above dc, while the third works
as a drain for the buffer solution. A sketch of the designs is
seen in Fig. 1.
The dc of a PFF device with three outlets can be calculated
from the channel geometry as follows.19 The flow rate
through the pinched segment must equal the sum of flow
rates through the outlet channels, due to mass conservation.
Qpinched = Qsmall + Qlarge + Qdrain, (1)
to simplify the expression, the flow rates through the large
particle outlet and the drain are expressed in terms of the
small particle outlet.
Qpinched = (1 + α + β)Qsmall, (2)
where α and β are the ratios of hydraulic resistances between
the small particle outlet and the respective other outlet (Rs/Rl
and Rs/Rd). It is often assumed that microfluidic channels
have a constant flow profile, however Andersen et al.19
pointed out that this assumption only holds for large channel
aspect ratios, H/W ≫ 1 and W/H ≫ 1, and not for cross sec-
tions with small aspect ratios as in the pinched segment.
Therefore the velocity profile, νxĲy,z), must be taken into
account, and the flow rates are calculated by integrating the
velocity profile in the pinched segment across the channel
width (y-direction) and the channel height (z-direction). Thus
eqn (2) becomes,
(3)
note that the critical diameter, dc, appears in the equation.
The velocity of rectangular channels can be found numeri-
cally by solving the Navier–Stokes equation with no-slip
boundary conditions at the wall.20 The optimal hydraulic
resistance ratio (α) was then calculated by inserting the
expression for the velocity in eqn (3) and solving for α.
There are many sets of dimensions that yield the desired
critical diameter, some more practical than others. The larg-
est cell aggregates are expected to have a size of around 20
μm, therefore the channel height was chosen to be 30 μm to
avoid clogging. The lengths were chosen by letting the outlet
channels go straight from the pinched segment to the out-
lets. The injection molded chip has a diameter of 5 cm, so
the channel lengths have to be in the centimeter range.
Therefore only the channel widths were left to be optimized
using eqn (3). We prepared two devices: the first device,
referred to as non-adjusted PFF, has a dc that is suitable for
separation when applying pressure to the sample and buffer
inlet only. The second device has a dc that is adjusted by
applying a pressure on the drain. It is referred to as adjust-
able PFF. The final design parameters are listed in Table S1
in the ESI.† In Table 1 we show that dc cannot be calculated,
but must be measured experimentally.
2.2. Fabrication
A nickel shim for injection molding was fabricated using
standard clean room processes.21,22 A 150 mm silicon wafer
was treated with hydrofluoric acid and coated with positive
photoresist. The resist was developed and the silicon wafer
was etched 30 μm using deep reactive-ion etching. The left-
over resist was removed by plasma ashing and acetone. A
nickel–vanadium seed layer was sputtered onto the wafer,
and a 300 μm thick nickel layer was electroplated on top.
Finally the silicon was removed using a KOH etch and the
shim was cut out to fit in the injection molder. The devices
were injection molded using the polymer TOPAS® 5013L-10
at a mold temperature of 120 °C, a holding pressure of 1500
bar and an injection rate of 20 cm3 s−1 to 45 cm3 s−1. The
total injection and cooling time was around 70 s pr. device.
The injection molder was equipped with a tool that creates
12 Luer fittings on each chip, which ensures easy connection
to the equipment. Finally the microchannels on each chip
were sealed with a 500 μm thick TOPAS® 5013L-10 foil using
UV-assisted bonding. The chips and lids were exposed to UV-
light from a mercury arc lamp for 30 s and then bonded at
120 °C and a pressure of 51 bar for 5 min using a P/O/Weber
press.
2.3. Cell culture and sample preparation
The following fluorescent polystyrene beads were used for
experiments: 2.1 μm blue (Duke Scientific), 5.1 μm green
(Magsphere Inc.), 7 μm green (Magsphere Inc.), 10 μm
orange (Invitrogen), and 15 μm orange (Invitrogen). Bead
solutions were prepared by mixing the different beads with
Milli-Q water and 0.1% Triton X-100 to a total concentration
Table 1 Calculated, simulated and measured critical diameter of the two
PFF designs. The calculations are based on channel dimensions, the mea-
sured sizes are based on bead experiments, and the simulated values are
based on semi-3D simulations, where the corner effect has been taken
into account
Calc. dc
[μm]
Simulated dc
[μm]
Measured dc
[μm]
Non-adjusted PFF 13.1 10.2 7.6 ± 0.4
Adjustable PFF 8.3 7.7 5.8 ± 0.3
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of 5 × 105 particles mL−1. The solutions consisted of 15% 2.1
μm beads, 20% 5.1 μm beads, 40% 7 μm beads, 20% 10 μm
beads and 5% 15 μm beads. All solutions were degassed in
an ultrasonic bath before experiments. Milli-Q water and
0.1% Triton X-100 was used to wet the devices before the
sample was introduced, and as buffer solution for all experi-
ments with beads.
The human colon adenocarcinoma LS174T cells were
obtained from B. H. Tom (Northwestern University Medical
Center, Chicago).23 The cell line was cultured in complete
Dulbecco's Modified Eagle Medium (DMEM; Life Technolo-
gies) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Life Technologies) and 1% penicillin/streptomy-
cin (Invitrogen). Cells were incubated at 37 °C in a humidi-
fied environment at 10% CO2 and were grown to 60–80%
confluence before next passage or further experiment.
Blood specimens were drawn from healthy donors after
obtaining informed consent. All specimens were collected
into BD Vacutainer CPT tubes (Becton Dickinson) containing
sodium heparin/Ficoll and were processed within 2 hours
according to the manufacturer's protocol. Following centrifu-
gation at 1500 × g (room temperature) for 15 min, the white
blood cell suspension was collected, washed twice in PBS
(1000 × g, room temperature, 10 min), and finally the cells
were suspended in FACSFlow.
For separation measurements, LS174T cells were stained
with calcein AM (Molecular Probes) and WBC's with either
Hoechst 33342 (Thermo Scientific) or CD45-PE (Becton Dick-
inson), and subsequently mixed in a ratio of 1 : 1.
Before cell separation experiments devices were wet with
degassed Milli-Q water and 0.1% Triton X-100 and then
flushed with degassed buffer solution (FACSFlow, BD). All
Luer fittings were then emptied and rinsed with FACSFlow to
get rid of leftover Triton X-100. FACSFlow was used as buffer
solution for all cell experiments.
2.4. Separation measurements
In this study, either solutions containing hard polystyrene
spheres or WBCs spiked with LS174T cancer cells were used.
In our study we perform an experiment with polymer beads
to determine the critical diameter of a PFF separation for
hard spheres. Previously, bead separation has mostly been
demonstrated on simple solutions containing two bead types
that do not overlap in size. These simple solutions do not
represent biological samples very well and cannot be used to
determine the critical diameter of a system. The bead sample
is a blend of fluorescent polymer beads with diameters from
2.1 μm to 15 μm. The size distribution of the beads is contin-
uous and there are small overlaps between beads of different
colors, creating a good model system to determine the critical
diameter of the separation over a continuous range of values.
To conduct separation experiments, samples were pipetted
into the Luer fittings on chip and pushed through the device
using a pressure-driven flow controller (Fluigent MFCS-EZ).
Experiments were monitored using an inverted fluorescence
microscope (Nikon Eclipse TE2000-U) coupled to an EMCCD
camera (Photometrics Cascade II:512) or a Brunel SP98F
inverted fluorescence microscope (Brunel Microscopes Ltd).
After experiments, images were taken of all particles in the
two outlets and the drain. The images were analyzed using a
script in MATLAB version R2013b software to extract the size
distribution of each bead or cell type from the fluorescence
images. The size of each particle was found by fitting
circles to the beads/cells and calculating the corresponding
diameter.
2.5. Critical diameter measurements
The separation efficiency of the cancer cell measurements
was evaluated by calculating the recovery of cancer cells and
the removal of WBCs, which we define as the number of cells
in the targeted outlet divided by the total number of cells,
, where Nx is set to Nsmall for WBC
removal and Nlarge for cancer cell recovery. No particles went
to the drain for most of the pressure settings used in the
experiments except for particles appearing very large such as
aggregates of cells. After experiments we measured the size of
all particles in the outlets, and used the size distributions to
determine the critical diameter, dc. For each particle size the
probability for going towards the large particle outlet is esti-
mated as the proportion of particles in the large particle out-
let. In the ideal case the estimated probability could be
described by a step function jumping from 0 to 1 at dc. How-
ever particles with a size close to dc have a finite probability
for going towards either outlet. The best estimate for dc is
determined as the size where particles have a 0.5 probability
of going towards the large particle outlet, and this size is
found by fitting the estimated probability to an error function
modified to output values between 0 and 1:
where a and b are fitted parameters describing position and
slope of the function. MATLAB was used to fit the error func-
tion to the data. The stated uncertainties in measured param-
eters correspond to half the distance from the upper to the
lower bounds on the 95% confidence interval. Error bars on
plots represent the standard deviation. Information on how
the error bars were calculated can be found in the ESI.†
2.6. Simulations
The devices were simulated in the finite element simulation
software COMSOL version 4.3. The critical diameter of the
devices was determined using semi-3D simulations as
described by Vig and Kristensen.24 Effects relating to cell
deformation were investigated using 3D simulations of a sec-
tion around the pinched segment. No-slip boundary condi-
tions were applied to all channel walls, and the pressures at
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the inlets and outlets were set to values used in the experi-
ments. Furthermore it was assumed that particles do not dis-
turb the flow.
3. Results and discussion
3.1. Hard sphere measurements
A blend of polymer beads with a broad size distribution was
separated by size through the device in order to test the
method for determining the critical diameter dc. For the ini-
tial experiments the sample flow rates were 30 μL h−1 to 50
μL h−1 depending on the design, and the flow was not
adjusted by any pressure at the outlets. The experiments were
run until at least 1000 beads had been sorted, equivalent to 2
μL of sample. The setup allows processing of larger samples,
however, this would prevent optical visualization of beads in
the outlets. All beads were counted and analyzed, and we
extracted the critical diameter of the separation using our
described method. Fig. 2 shows the result of a separation in
an adjustable PFF device. The 2 μm beads are not repre-
sented on the figure because they were not fully pinched.
The data fits well to the error function, but the analysis
method results in a critical diameter of 5.8 μm ± 0.3 μm,
which is much smaller than the expected diameter of 8.6 μm.
The size distribution in Fig. 2 shows that the majority of 5
μm beads are collected in the small particle outlet, while the
majority of 7 μm beads are collected in the large particle out-
let. It is therefore reasonable that the critical diameter is in
the range 5 μm to 7 μm, as measured.
The bead measurements show that the critical diameter is
different from the calculated value. The displacement of
beads due to an effect at the end of the pinched segment
described by Vig and Kristensen24 could explain this discrep-
ancy. Using semi-3D simulations they showed that at the cor-
ner at the end of the pinched segment, streamlines are
squeezed closer to the wall than in the pinched segment.
This corner effect forces particles to follow streamlines fur-
ther away from the wall, and will decrease the critical diame-
ter. We made similar semi-3D finite element simulations,
and found a modified critical diameter, by measuring the
shortest distance from the wall to the outer streamline going
into the small particle outlet.
The distance from the pinched segment wall to the outer
streamline was measured as 4.2 μm, corresponding to a criti-
cal diameter of 8.4 μm, which is close to the value of 8.3 μm
found from the calculations. The smallest distance from the
corner to the outer streamline was 3.85 μm, corresponding to
a critical diameter of 7.7 μm. The same simulation was car-
ried out on both designs, and the simulated critical diame-
ters are summarized in Table 1, together with the critical
diameters calculated from the geometry of the designs, and
the critical diameters determined from bead experiments.
The corner effect accounts for some of the difference
between calculated and measured critical diameter. Other
influences on the critical diameter include deviations in the
replication of the design during the fabrication and particle
disturbances of the flow. The results indicate that the mea-
surement of the critical diameter presented in Fig. 2 is more
accurate than the theoretical calculations and the simula-
tions. An advantage of PFF is that the critical diameter can
be changed by applying pressure to the outlets. Using our
new analysis method, microliter-sized bead samples can
be used to find the optimal flow conditions, before
experimenting on valuable cell samples.
It has previously been reported that filters with a size of
8 μm work well for cancer cell enrichment,25 thus 8 μm was
expected to be the ideal critical diameter. The adjustable PFF
devices have a critical diameter that is too small for separa-
tion of CTCs and WBCs. It can be increased by applying a
pressure at the drain, and it was found that a pressure of
40% of the buffer inlet pressure was suitable such that the
critical diameter for hard spheres is 8 μm.
There is no limitation to the adjustability of the dc in a
PFF device. However it does not make sense to reduce the dc
below the pinching width or increase it above the size of the
biggest particles that can flow freely in the device (about 2/3
of the depth).
3.2. Cancer cell separation by PFF
We used non-adjusted PFF devices to separate WBCs and
cancer cells. We have measured the critical diameter of the
device to be 7.6 μm with polymer beads. The devices were ini-
tially run with a sample flow rate of 10 μL h−1. We show the
size distribution of each cell type in the small and large
Fig. 2 Critical diameter measurement with polymer beads. (A)
Fluorescence images of 10 μm and 15 μm beads. (B) The original image
with white circles showing the fit to each bead. (C) Histogram with
size distributions of beads in the small particle outlet. (D) Histogram
with size distributions of beads in the large particle outlet. (E)
Proportion of beads in the large particle outlet plotted as a function of
size, and a fitted error function. The measured critical diameter,
marked by the black dashed lines, is 5.8 μm ± 0.3 μm.
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particle outlet in Fig. 3A–D. From the histograms we plot the
proportion of WBCs in the large particle outlet (Fig. 3E) and
of cancer cells in the large particle outlet (3F) as a function
of cell size.
In the non-adjusted PFF device with a critical diameter of
7.6 μm calibrated with polymer beads, we find at 10 μl h−1
flow rate nearly all WBCs up to a diameter of 9 μm in the
small particle outlet, and nearly all cancer cells with a diame-
ter of 7.9 μm and above in the large particle outlet.
The first observation is that the critical diameter for can-
cer cells is 7.9 μm ± 0.15 μm, similar to polymer beads. How-
ever, the critical diameter for WBCs is larger, 9.2 μm ± 2.1
μm. This difference in critical diameter is an advantage and
resulted in a recovery of 96% cancer cells together with a
removal of 93.6% WBCs. We spiked the WBC sample with
LS174T cells at 1 : 1, however, we observe that in the outlets
the WBCs are more frequent. We observed that cancer cells
sediment faster in the inlets. Therefore we expect to have a
lower frequency for the cancer cells.
A good separation that should allow for isolation of CTCs
was obtained, however, the experiment was performed at
sample flow rates that are too low for applications where at
least 10 mL of sample must be sorted. We investigated how
increasing flow rates affect the recovery and removal of cells.
The results from a series of experiments are seen on Fig. 3G.
The CTC recovery is independent of flow rates, however the
WBC removal drops rapidly as the flow rate is increased. A
possible reason is that the inertia of the WBCs increases with
increasing flow rates, and eventually becomes large enough
to deflect them from the streamlines going around the corner
and into the small particle outlet. This also explains why can-
cer cell recovery is unaffected, since the cancer cells move
along straight trajectories into the large particle outlet. The
throughput of a PFF device can be increased by increasing
the depth. In our device the depth is limited by the maxi-
mum aspect ratio allowed by the nickel electroplating step
and the replication in polymer by injection moulding.
3.3. Cancer cell separation by adjustable-PFF
The adjustable-PFF devices were also tested with WBC sam-
ples spiked with cancer cells to demonstrate that the critical
diameter of PFF devices can be adjusted without loss of sepa-
ration efficiency. A sample flow rate of 50 μL h−1 was used,
and the critical diameter was adjusted by applying a pressure
at the drain outlet. The results are shown in Fig. 4A–F.
The measured recovery and removal are comparable to the
values measured for the non-adjusted PFF devices at equiva-
lent flow rates, see Fig. 3G. Thus we show that PFF devices
with an arbitrary critical diameter can be tuned to fit the sep-
aration of a specific sample.
A difference in critical diameter between cell types was
again observed in the measurements as seen in Fig. 4E. Here
the critical diameter of each cell type is plotted for experi-
ments where the pressure on the drain was changed relative
to the pressure on the buffer inlet. As expected the critical
diameter for both cell types increases with an increasing
pressure on the drain, and the critical diameter of the WBCs
stays above the critical diameter of the cancer cells, thus
ensuring that the overall separation efficiency is high. The
difference in critical diameter is an advantage and is
exploited to get a better separation than expected from the
overlapping size distributions.
3.4. How cell deformability influences PFF
We demonstrated that WBCs have a larger critical diameter
than cancer cells in a PFF device. We can estimate that the
difference in dc for the WBCs and the cancer cells improves
the removal of WBCs from 85.8% to 93.6%.§ A possible
source of error on the critical diameter measurements is that
cancer cells are expected to be less spherical than WBCs. This
would lead to an overestimation of the shortest axis of the
Fig. 3 Separation of WBCs and LS174T cells in a PFF device with a
fixed critical diameter at 10 μL h−1. (A–B) Size distribution of WBCs in
each outlet after separation. (C–D) Size distribution of cancer cells in
each outlet after separation. (E) Proportion of WBCs in the large
particle outlet. The critical diameter is marked by black dashed lines
and reads 9.2 ± 2.1 μm. (F) Proportion of cancer cells in the large
particle outlet. The critical diameter is marked by black dashed lines
and reads 7.9 ± 0.15 μm. The recovery was 96.0% for cancer cells with
a 93.6% removal of WBCs. (G) Recovery of cancer cells and removal of
WBCs at different sample flow rates.
§ Counting all WBCs larger than 7.9 μm in the small particle outlet as being in
the large particle outlet.
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cancer cells when measured by fluorescence imaging. The
critical diameter of cancer cells would then be overestimated,
which would mean that the difference in critical diameter
between WBCs and cancer cells is indeed even more pro-
nounced that we observe here. We hypothesize instead that
the difference in critical diameter is due to a difference in
deformability at high shear rate/deformation that would
make the cancer cells appear more rigid than the WBCs and
explain why they had a measured critical diameter closer to
the one for beads (7.6 μm).
Our hypothesis may seem contradictory with the result of
mechanical studies on cancer cells such as AFM studies26,27
that show cancer cells are more deformable than other cells.
However, in most mechanical measurements of cells, the
Young's modulus is measured locally.28 In our device, the
whole cell is deformed in a Pouiseuille flow in a capillary as
described elsewhere.29–33
We investigated three possible effects in the PFF devices
that could make the cell deformability influence the critical
size of the cell separation: The elongation flow when cells
move from the sample inlet channel to the pinched segment,
the shear rate in the pinched segment, and squeezing at
the corner between the pinched segment and the outlet
channels.
We model the shear rate experienced by cells when travel-
ling from the inlet to the pinched segment by finite element
simulations, as seen in Fig. 5A. The largest cell deformation
is expected to be at the corner at the end of the pinched seg-
ment, where the corner effect causes hard spheres or cells to
change to streamlines further away from the wall, whereas
soft cells can deform and follow the streamlines they occupy
in the pinched segment. We estimated the shear rates at the
corner between the pinched segment and the small particle
Fig. 4 Separation of WBCs and LS174T cells in a PFF device with a
fixed critical diameter at 10 μL h−1. (A–B) Size distribution of WBCs in
each outlet after separation. (C–D) Size distribution of cancer cells in
each outlet after separation. (E) Proportion of WBCs in the large
particle outlet. The critical diameter is marked by black dashed lines
and reads 9.5 ± 0.35 μm. (F) Proportion of cancer cells in the large
particle outlet. The critical diameter is marked by black dashed lines
and reads 8.9 ± 0.4 μm. The recovery was 91.4% for cancer cells with
a removal of 89.7% WBCs. (G) Measured critical diameter of cancer
cells and WBCs vs. the pressure ratio between the buffer inlet and the
drain.
Fig. 5 Shear rates in the PFF device. (A) Simulation of shear rate at a
middle height in the PFF device. The shear rare is greatest at the wall
in the pinched segment. (B) 3D simulation at the corner between the
pinched segment and the small particle outlet channel. The shear rate
is constant along the wall and then increases at the corner. The color
scale fits both figure A and B. (C) Illustration of the squeezing of
streamlines at the transition from the pinched segment: a hard particle
is forced to follow a streamline further away from the pinched
segment wall because of the corner effect. A soft particle is deformed
even further due to increased shear rate at the corner and follows its
initial streamline. The particles are included to illustrate the different
behaviours of soft and hard particles and were not part of the
simulation. (D) Simulated flow velocity along streamlines going from
the sample inlet channel to the pinched segment. All streamlines are at
a middle height in the channel, and starting at different y-coordinates
in the inlet channel, as marked on figure A. The plotted velocities were
measured between the x-coordinates also marked on figure A.
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outlet channel using 3D simulations. The results from the
simulations are seen in Fig. 5B. The shear rate is constant
along the wall and then increases at the corner to approx.
30 000 s−1 for a sample flow rate of 33 μL h−1. This is much
larger than the shear rates used by Beech et al.34 to deform
red blood cells in lateral displacement structures. Thus the
shear rates are large enough to deform soft cells, which will
then get an increased critical diameter, while hard cells will
get a decreased critical diameter due to the so-called corner
effect. This is illustrated in Fig. 5C. The high shear rates com-
bined with the corner effect enhance the separation of hard
and soft particles with overlapping sizes, which is very advan-
tageous when separating cancer cells from WBCs.
Increasing the throughput of the device must be achieved
while keeping the flow velocity and shear rate at the same
level. This is possible by increasing the depth of the device.
We have also estimated the shear rate in the pinched seg-
ment. A top-view 3D simulation of the pinched segment is
seen in Fig. 5A. The illustrated plane is at a middle height,
and the highest shear rate is found along the wall in the
pinched segment. For a sample flow rate of 33 μL h−1 the
maximum shear rate is approx. 20 000 s−1. It is in the same
order of magnitude as the shear rate at the corner and is
expected to contribute to cell deformation as well.
Finally when cells move from the sample inlet channel to
the pinched segment, they experience an increase in velocity
due to the incoming fluid from the buffer inlet. Simulations
were used to investigate this elongation flow. It is assumed
that the cells travel at a height in the middle of the channel.
The velocity along streamlines starting at different positions
in the sample inlet is plotted in Fig. 5D. The plot shows that
the cells move at a constant velocity and then experience a
linear velocity change as they move into the pinched seg-
ment. The change in velocity gives rise to a shear rate equal
to the slope of the velocity curve. As opposed to the other cell
deformation contributions, the shear rate from the elonga-
tion flow depends on the position of the cells before they are
aligned. This could therefore decrease the separation effi-
ciency. However the maximum shear rate is approx. 1000 s−1,
which is much smaller than the shear rates along the wall
and at the corner of the pinched segment. Thus elongation
flow is not expected to contribute to cell deformation.
In our device the cells are in contact with the channel wall
when they experience high shear rate. The time scale is much
smaller than the relaxation time (1.1 s for WBCs in ref. 35).
This situation may be comparable to the situation of margin-
ation studied by Fedosov et al.35 In this study, the shear rate
is in the order of 100 s−1 and the deformation is 5%. Others
report deformability up to 30% for WBCs adherent to a sur-
face under similar conditions (in ref. 35 and references
therein). We estimate that the cells experience a shear rate
more than two orders of magnitude larger in our PFF device.
We can thus reasonably expect that cancer cells and WBCs
would deform 4% and 17% respectively in order for their size
to appear to be 7.6 μm at the time of the separation.¶ Consid-
ering the rather large deformation, the observation that
cancer cells have a larger nucleus may be relevant to our dis-
cussion and could explain why above a certain deformation,
the cancer cells appear less deformable than WBCs. This has
already been exploited by Tang et al., who used microfilters
to separate cancer cells from whole blood. They observed that
WBCs were able to deform and squeeze through 6.5 μm fil-
ters, while cancer cells were caught because of their rigid
nucleus.36
Finally, in this discussion it may be important to consider
the dynamics of potential deformations. In our experiment
the cell viability is not expected to change since Hur et al.30
did not see a significant change when using inertial focusing
with high shear stresses to classify cells according to
deformability. This may be due to the very short exposure to
high shear rates as it is in contrast with the loss of cell viabil-
ity at prolonged flow above 300 s−1 reported by Barnes et al.37
We have shown that the high shear rate combined with
the corner effect in PFF devices may be the reason for the
improved separation of cancer cells and WBCs. It should be
noted that cell deformation has previously been used to
improve other microfluidic size-separation devices based on
deterministic lateral displacement arrays34 and inertial
microfluidics.30
4. Conclusion
We have separated cancer cells and WBCs at efficiencies over
90% using injection molded PFF devices. We measured the
size of all separated cells and showed that there is a signifi-
cant difference in critical diameter between WBCs and cancer
cells. We suggest this comes from a difference in cell
deformability, which improves the separation efficiency. We
have used finite element simulations to investigate the cell
deformation at three critical places on the devices, and the
largest contribution is the shear rate at the corner of the
pinched segment, just before the separation.
We have demonstrated that the critical diameter of PFF
devices can be changed successfully without a loss of separa-
tion efficiency. The highest separation efficiencies were
obtained at sample flow rates of 10 μL h−1. At higher flow
rates the cancer cell recovery was unaffected, whereas the
WBC removal decreased. We believe the WBC trajectories
changed because of increased inertia of the cells. Further
investigations are needed to determine the exact cause and
improve the PFF design, so a higher sample throughput can
be accomplished without a decrease in WBC removal.
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